FDG PET findings of chronic myeloid leukemia in the chronic phase before and after treatment

被引：26
作者：
Nakajo, Masatoyo
Jinnouchi, Seishi
Inoue, Hirosaka
Otsuka, Maki
Matsumoto, Tadashi
Kukita, Toshimasa
Tanabe, Hiroaki
Tateno, Rie
Nakajo, Masayuki
机构：
[1] PET Ctr, Atsuchi Mem Clin, Dept Radiol, Kagoshima 8920841, Japan
[2] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Radiol, Kagoshima 890, Japan
[3] Imamura Hosp, Dept Hematol, Kagoshima, Japan
[4] Kagoshima Med Ctr, Natl Hosp Org, Dept Hematol, Kagoshima, Japan
来源：
CLINICAL NUCLEAR MEDICINE | 2007年 / 32卷 / 10期
关键词：
FDG PET; PET/CT; diffuse bone marrow FDG uptake; chronic myeloid leukemia; POSITRON-EMISSION-TOMOGRAPHY; CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW; LYMPHOMA; INVOLVEMENT; THERAPY;
D O I：
10.1097/RLU.0b013e318148b467
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
We report 2 patients with chronic myeloid leukemia in the chronic phase showing diffusely increased F-18 fluorodeoxyglucose (FDG) uptake in the bone marrow before treatment. Follow-up FDG positron emission tomography (PET) scans were performed in a patient after cessation of treatment and in the other under treatment. Both FDG PET findings showed reduced FDG uptake in the bone marrow. A series of these FDG PET findings suggest the usefulness of FDG PET for the diagnosis and monitoring of chronic myeloid leukemia after treatment.
引用
收藏
页码：775 / 778
页数：4
相关论文
共 16 条
[1]   Hematopathologic and cytogenetic findings in imatinib mesylate-treated chronic myelogenous leukemia patients: 14 months' experience [J].
Braziel, RM ;
Launder, TM ;
Druker, BJ ;
Olson, SB ;
Magenis, RE ;
Mauro, MJ ;
Sawyers, CL ;
Paquette, RL ;
O'Dwyer, ME .
BLOOD, 2002, 100 (02) :435-441
[2]   Myelofibrosis on F-18 FDG PET imaging [J].
Burrell, SC ;
Fischman, AJ .
CLINICAL NUCLEAR MEDICINE, 2005, 30 (10) :674-674
[3]   Detection of lymphoma in bone marrow by whole-body positron emission tomography [J].
Carr, R ;
Barrington, SF ;
Madan, B ;
O'Doherty, MJ ;
Saunders, CAB ;
van der Walt, J ;
Timothy, AR .
BLOOD, 1998, 91 (09) :3340-3346
[4]   Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging [J].
Chiang, SB ;
Rebenstock, A ;
Guan, L ;
Alavi, A ;
Zhuang, HM .
CLINICAL NUCLEAR MEDICINE, 2003, 28 (08) :674-676
[5]   Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine [J].
Cook, GJR ;
Maisey, MN ;
Fogelman, I .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (10) :1363-1378
[6]   Enhanced marrow [18F]fluorodeoxyglucose uptake related to myeloid hyperplasia in Hodgkin's lymphoma can simulate lymphoma involvement in marrow [J].
Elstrom, RL ;
Tsai, DE ;
Vergilio, JA ;
Downs, LH ;
Alavi, A ;
Schuster, SJ .
CLINICAL LYMPHOMA, 2004, 5 (01) :62-64
[7]   Chronic myelogenous leukemia: Biology and therapy [J].
Faderl, S ;
Talpaz, M ;
Estrov, Z ;
Kantarjian, HM .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (03) :207-219
[8]   Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec) - Bone marrow histopathology and correlation with genetic status [J].
Frater, JL ;
Tallman, MS ;
Variakojis, D ;
Druker, BJ ;
Resta, D ;
Riley, MB ;
Hrisinko, MA ;
Peterson, LC .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2003, 119 (06) :833-841
[9]   Hematopoietic cytokine-mediated FDG uptake simulates the appearance of diffuse metastatic disease on whole-body PET imaging [J].
Hollinger, EF ;
Alibazoglu, H ;
Ali, A ;
Green, A ;
Lamonica, G .
CLINICAL NUCLEAR MEDICINE, 1998, 23 (02) :93-98
[10]   Nontuberculous mycobacterial pulmonary infection in immunocompetent patients: Comparison of thin-section CT and histopathologic findings [J].
Jeong, YJ ;
Lee, KS ;
Koh, WJ ;
Han, J ;
Kim, TS ;
Kwon, OJ .
RADIOLOGY, 2004, 231 (03) :880-886
12